Bertil Lindahl Selected Research

Chest Pain (Chest Pains)

10/2019	Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain-the WESTCOR study: study design.
11/2018	High-Sensitivity Cardiac Troponin-Based Strategies for the Assessment of Chest Pain Patients-A Review of Validation and Clinical Implementation Studies.
1/2018	Experiences of a One-hour Algorithm in Chest Pain Patients With a Nonelevated Troponin T at Presentation.
1/2018	Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain.
11/2017	Early diagnosis of acute coronary syndrome.
9/2017	Impact of Sex on Cardiac Troponin Concentrations-A Critical Appraisal.
2/2017	Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation.
1/2017	A 0-Hour/1-Hour Protocol for Safe, Early Discharge of Chest Pain Patients.
4/2016	A 1-h Combination Algorithm Allows Fast Rule-Out and Rule-In of Major Adverse Cardiac Events.
5/2015	Two-hour diagnostic algorithms for early assessment of patients with acute chest pain--Implications of lowering the cardiac troponin I cut-off to the 97.5th percentile.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bertil Lindahl Research Topics

Disease

116	Myocardial Infarction 07/2022 - 01/2002
53	Acute Coronary Syndrome 06/2022 - 06/2002
32	Coronary Artery Disease (Coronary Atherosclerosis) 10/2019 - 05/2002
27	Heart Failure 06/2022 - 06/2002
25	Chest Pain (Chest Pains) 10/2019 - 08/2002
20	Cardiovascular Diseases (Cardiovascular Disease) 09/2021 - 06/2003
17	Heart Diseases (Heart Disease) 01/2022 - 10/2010
17	ST Elevation Myocardial Infarction 12/2021 - 12/2003
13	Necrosis 02/2022 - 01/2003
12	Inflammation (Inflammations) 12/2021 - 12/2003
9	Non-ST Elevated Myocardial Infarction 12/2021 - 10/2013
9	MINOCA 07/2021 - 04/2017
8	Infarction (Infarctions) 01/2021 - 02/2002
7	Stroke (Strokes) 11/2020 - 02/2015
6	Atrial Fibrillation 01/2019 - 10/2007
5	Thrombosis (Thrombus) 05/2021 - 05/2003
5	Hemorrhage 01/2021 - 02/2015
5	Unstable Angina 12/2017 - 01/2002
4	Atherosclerosis 10/2021 - 09/2008
4	Hypoxia (Hypoxemia) 01/2021 - 01/2017
4	Hypertension (High Blood Pressure) 01/2020 - 08/2010
4	Obesity 01/2018 - 07/2012
4	Ischemia 01/2016 - 07/2003
4	Diabetes Mellitus 01/2013 - 06/2002
4	Myocardial Ischemia (Ischemic Heart Diseases) 02/2010 - 08/2005
3	COVID-19 02/2022 - 12/2020
3	Ischemic Stroke 01/2021 - 12/2015
3	Left Ventricular Dysfunction 01/2019 - 08/2008
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2020
2	Wounds and Injuries (Trauma) 12/2018 - 01/2018
2	Cardiogenic Shock 01/2018 - 01/2017
2	Pulmonary Embolism 02/2017 - 10/2013
2	Aortic Dissection 02/2017 - 01/2017
2	Coronary Disease (Coronary Heart Disease) 01/2013 - 05/2002
2	Reperfusion Injury 12/2007 - 02/2007
1	Fibrosis (Cirrhosis) 06/2022
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	Peripheral Arterial Disease 09/2021
1	Pneumonia (Pneumonitis) 05/2021

Drug/Important Bio-Agent (IBA)

63	TroponinIBA 02/2022 - 05/2002
51	Troponin T (Troponin T1)IBA 02/2022 - 05/2002
50	Biomarkers (Surrogate Marker)IBA 07/2022 - 07/2003
39	Troponin IIBA 02/2022 - 06/2003
21	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2021 - 08/2002
18	trans-crotonin (CTN)IBA 01/2021 - 07/2012
18	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 08/2002
14	Dalteparin (Dalteparin Sodium)FDA Link 06/2012 - 05/2002
13	Oxygen (Dioxygen)IBA 01/2021 - 01/2005
10	C-Reactive ProteinIBA 07/2021 - 03/2003
8	Growth Differentiation Factor 15IBA 12/2015 - 02/2007
6	Natriuretic PeptidesIBA 05/2021 - 09/2004
6	Cystatin CIBA 09/2017 - 10/2004
5	Proteins (Proteins, Gene)FDA Link 06/2022 - 09/2015
5	Trinitrotoluene (TNT)IBA 02/2022 - 03/2003
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 12/2004
5	CreatinineIBA 01/2019 - 06/2002
4	MyoglobinIBA 12/2021 - 10/2004
4	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 02/2002
4	omega-Chloroacetophenone (Mace)IBA 01/2018 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 12/2021 - 12/2003
3	LDL CholesterolIBA 01/2021 - 01/2014
3	Angiotensin Receptor AntagonistsIBA 01/2021 - 04/2017
3	CytokinesIBA 01/2019 - 02/2007
3	GadoliniumIBA 01/2018 - 11/2015
3	fibrin fragment D (D-dimer)IBA 11/2017 - 02/2002
2	Fibroblast Growth Factor-23IBA 12/2021 - 10/2021
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2005
2	LigandsIBA 10/2021 - 01/2019
2	ReninIBA 01/2021 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 04/2017
2	oxidized low density lipoproteinIBA 01/2021 - 01/2014
2	TicagrelorIBA 01/2021 - 11/2020
2	insulin receptor-related receptor (IRR)IBA 12/2020 - 01/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 01/2020
2	DiureticsIBA 01/2020 - 02/2005
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2019 - 12/2015
2	Peroxidase (Myeloperoxidase)IBA 01/2019 - 02/2010
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019 - 05/2003
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019 - 12/2015
2	Adenosine Diphosphate (ADP)IBA 11/2018 - 01/2017
2	apixabanIBA 06/2017 - 02/2015
2	AdrenomedullinIBA 12/2015 - 10/2013
2	Indicators and Reagents (Reagents)IBA 10/2013 - 02/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2007 - 02/2007
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2006 - 10/2004
2	MB Form Creatine KinaseIBA 08/2005 - 10/2004
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2003 - 05/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	RANK LigandIBA 12/2021
1	X-Pro aminopeptidase (aminopeptidase P)IBA 12/2021
1	Amyloid (Amyloid Fibrils)IBA 12/2021
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 12/2021
1	Chitinase-3-Like Protein 1IBA 12/2021

Therapy/Procedure

31	Therapeutics 01/2022 - 05/2004
10	Percutaneous Coronary Intervention 07/2022 - 12/2013
7	Secondary Prevention 01/2021 - 09/2009
6	Patient Readmission 01/2021 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2020 - 10/2013
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 08/2004
2	Stents 01/2018 - 02/2015